PL393941A1 - Zastosowanie glikozydów mono-i diacyloglicerolu jako środków przeciwzapalnych - Google Patents

Zastosowanie glikozydów mono-i diacyloglicerolu jako środków przeciwzapalnych

Info

Publication number
PL393941A1
PL393941A1 PL393941A PL39394102A PL393941A1 PL 393941 A1 PL393941 A1 PL 393941A1 PL 393941 A PL393941 A PL 393941A PL 39394102 A PL39394102 A PL 39394102A PL 393941 A1 PL393941 A1 PL 393941A1
Authority
PL
Poland
Prior art keywords
diacylglycerol
glycosides
mono
inflammatory agents
inflammatory
Prior art date
Application number
PL393941A
Other languages
English (en)
Inventor
Erik Larsen
Arsalan Kharazmi
Soren Brogger Christensen
Lars Porskjaer Christensen
Kirsten Brandt
Original Assignee
University Of Aarhus
H:S Rigshospitalet
University Of Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Aarhus, H:S Rigshospitalet, University Of Copenhagen filed Critical University Of Aarhus
Publication of PL393941A1 publication Critical patent/PL393941A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
PL393941A 2001-11-21 2002-11-21 Zastosowanie glikozydów mono-i diacyloglicerolu jako środków przeciwzapalnych PL393941A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33208401P 2001-11-21 2001-11-21
US34160901P 2001-12-18 2001-12-18
US35839102P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
PL393941A1 true PL393941A1 (pl) 2011-06-20

Family

ID=27406836

Family Applications (2)

Application Number Title Priority Date Filing Date
PL370888A PL213644B1 (pl) 2001-11-21 2002-11-21 Zastosowanie glikozydów mono- i diacyloglicerolu do wytwarzania leku do leczenia, lagodzenia lub profilaktyki stanów zapalnych
PL393941A PL393941A1 (pl) 2001-11-21 2002-11-21 Zastosowanie glikozydów mono-i diacyloglicerolu jako środków przeciwzapalnych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL370888A PL213644B1 (pl) 2001-11-21 2002-11-21 Zastosowanie glikozydów mono- i diacyloglicerolu do wytwarzania leku do leczenia, lagodzenia lub profilaktyki stanów zapalnych

Country Status (9)

Country Link
US (2) US7084122B2 (pl)
EP (1) EP1453844B1 (pl)
JP (2) JP4716655B2 (pl)
CN (1) CN100469784C (pl)
AU (1) AU2002366210A1 (pl)
DK (1) DK1453844T3 (pl)
NO (1) NO334587B1 (pl)
PL (2) PL213644B1 (pl)
WO (1) WO2003043613A2 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004153D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
GB0004152D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel compounds
GB0004151D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
AR035700A1 (es) * 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
SE0102640D0 (sv) * 2001-07-31 2001-07-31 Astrazeneca Ab Novel compounds
SE0203304D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Coumpounds
JP3914519B2 (ja) * 2003-06-06 2007-05-16 株式会社スピルリナ研究所 グリセロ糖脂質化合物を含有してなるリパーゼ活性阻害剤
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
KR101245440B1 (ko) * 2003-09-12 2013-03-19 액세스 비지니스 그룹 인터내셔날 엘엘씨 사이토킨 조절물질 및 관련된 용도
JP3790767B2 (ja) * 2004-06-30 2006-06-28 森下仁丹株式会社 脂肪代謝改善組成物
US20070269540A1 (en) * 2006-05-16 2007-11-22 Morishita Jintan Co., Ltd. Fat metabolism improving agent
JP4866067B2 (ja) * 2005-11-22 2012-02-01 株式会社ファンケル メラニン産生抑制剤
US8435588B2 (en) 2005-11-23 2013-05-07 The Coca-Cola Company High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith
AU2006345937B2 (en) * 2006-07-03 2011-08-11 Hyben Vital Licens Aps A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material
US7547455B2 (en) * 2006-09-20 2009-06-16 Academia Sinica Cancer and inflammatory disorder treatment
KR100772078B1 (ko) 2006-11-07 2007-10-31 한국기초과학지원연구원 갈조류 지충이로부터 분리된 신규모노갈락토실디아실글리세롤 화합물
JPWO2008108001A1 (ja) * 2007-03-02 2010-06-10 株式会社東洋新薬 ガラクト脂質
AU2008339944B2 (en) 2007-12-21 2014-05-01 Finzelberg Gmbh & Co. Kg Preparations with rosehip extracts, and method of producing rosehip extracts
NZ567712A (en) * 2008-04-24 2010-11-26 Fonterra Cooperative Group Ltd Compositions and methods for maintaining bone health or reducing bone loss
MX2010011922A (es) 2008-05-06 2011-03-02 Finzelberg Gmbh & Co Kg Star Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos.
WO2010048955A1 (en) 2008-10-30 2010-05-06 Hyben Vital Licens Aps Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
DK177605B1 (en) 2010-03-16 2013-11-18 Hyben Vital Licens Aps Compositions of rose hips enriched with seeds of rose hips and their use as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and joint diseases such as arthritis and/or osteo-arthritis
EP2389816A1 (en) 2010-05-25 2011-11-30 Nestec S.A. Synergistic antioxidant composition
CN103037883B (zh) 2010-06-25 2014-12-10 合飞研究(Ip)Pre股份有限公司 用以改善性良好度的组合物
TWI558403B (zh) * 2013-06-04 2016-11-21 中央研究院 富含半乳糖脂之植物萃取物及其用途
JP6339426B2 (ja) * 2014-06-30 2018-06-06 株式会社ファンケル グリセロ糖脂質を含有する組成物の製造方法及びグリセロ糖脂質含有組成物
SG11201811595SA (en) * 2016-06-27 2019-01-30 Ohio State Innovation Foundation Liponucleotide-based therapy for ards
CN106983763B (zh) * 2017-04-25 2021-04-20 中国海洋大学 单半乳糖基二酰基甘油酯及其制备方法与用途
CN110201026B (zh) * 2019-07-15 2021-09-24 青岛农业大学 一种非抗生素型结肠炎修复制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271270A (ja) * 1992-03-27 1993-10-19 Nippon Paper Ind Co Ltd 糖ーグリセロール誘導体とその合成法
JP3298723B2 (ja) * 1993-03-30 2002-07-08 武田食品工業株式会社 発癌プロモーション抑制組成物
AU6821294A (en) * 1993-04-30 1994-11-21 Rodner R. Winget Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
JPH07149786A (ja) * 1993-11-26 1995-06-13 Sagami Chem Res Center グリセロ糖脂質及び発癌プロモーター阻害剤
US5663151A (en) 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5486536A (en) * 1994-08-15 1996-01-23 The Regents Of The University Of Michigan Sulfatides as anti-inflammatory compounds
DE19634021A1 (de) * 1996-08-23 1998-02-26 Beiersdorf Ag Antiadhäsive Glycoglycerolipide
DE19634019A1 (de) 1996-08-23 1998-02-26 Beiersdorf Ag Gegen Mikroogranismen, Viren, Parasiten und Protozoen wirksame Glycoglycerolipide
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
US6024960A (en) * 1998-04-17 2000-02-15 Otto Torbjorn Hansen And Marianne Hansen Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis

Also Published As

Publication number Publication date
WO2003043613A3 (en) 2004-03-25
US20050049205A1 (en) 2005-03-03
NO334587B1 (no) 2014-04-14
EP1453844A2 (en) 2004-09-08
CN100469784C (zh) 2009-03-18
EP1453844B1 (en) 2013-11-20
JP2005513023A (ja) 2005-05-12
US20030139350A1 (en) 2003-07-24
CN1606563A (zh) 2005-04-13
NO20042112L (no) 2004-07-09
US7084122B2 (en) 2006-08-01
AU2002366210A8 (en) 2003-06-10
PL213644B1 (pl) 2013-04-30
WO2003043613A2 (en) 2003-05-30
DK1453844T3 (da) 2014-02-10
AU2002366210A1 (en) 2003-06-10
JP2010215660A (ja) 2010-09-30
PL370888A1 (pl) 2005-05-30
JP4716655B2 (ja) 2011-07-06

Similar Documents

Publication Publication Date Title
AU2002366210A8 (en) Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
IL160990A0 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
AU2001291859A1 (en) Use of copolycarbonates
AP2003002713A0 (en) 3'prodrugs of 2'-deoxy-b-l-nucleosides
TW493722U (en) Improved structure of lampwick
TW424905U (en) Improved structure of drum-beater
TW503784U (en) Improved structure of pulverizer
TW503783U (en) Improved structure of pulverizer
TW459823U (en) Improved structure of washbasin
TW494780U (en) Structure of swimmeret
TW461568U (en) Structure improvement of pressing-switch
TW496608U (en) Structure improvement of row-wire fixing-stage
TW448780U (en) Improved structure of goggles
TW448778U (en) Improved structure of goggles
TW568132U (en) Improved structure of spatula
TW525471U (en) Structure of tissue box
TW488312U (en) Improved structure of handcar
TW589936U (en) Improved structure of aqua-aerator
TW499920U (en) Improved structure of hoverbed
TW552878U (en) Improved structure of hairclip
TW552879U (en) Improved structure of hairclip
TW567750U (en) Improved structure of panty-hose
TW418623U (en) Structure of aglet
TW496600U (en) Structure of socket panel
TW480914U (en) Improved structure of fishpot

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)